Nancy Brown

A multidisciplinary cross section of the Vanderbilt University Medical Center and Vanderbilt University community gathered Tuesday during StrategyShare18, an interactive half-day event to share ideas, invite collaborations and spur new initiatives. Read More

Nancy Brown, M.D., Hugh J. Morgan Professor and chair of the Department of Medicine in the Vanderbilt University School of Medicine, delivered a mixture of accolades and challenges to the dozens of faculty members, residents and fellows who attended her annual State of the Department address last week in Langford Auditorium. Read More

The Alliance for Academic Internal Medicine’s APM Council will award Vanderbilt’s Nancy Brown, MD, the 2018 Robert H. Williams, MD, Distinguished Chair of Medicine Award during the APM Winter Meeting, March 18-21 in San Antonio. Read More

Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine in the Vanderbilt University School of Medicine, shared a bumper crop of good news in her annual State of the Department address last week. Read More

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN). Read More

Vanderbilt University School of Medicine has long been recognized as a national leader in biomedical research. Nowhere is this more evident than in the school’s Department of Medicine, which, during the 2016 federal fiscal year that ended Sept. 30, broke another record. Read More

Nancy Brown, M.D., chair of the Department of Medicine, ticked off a wealth of accomplishments for the 2016 academic year at the recent State of the Department of Medicine Address Read More

Vanderbilt Genetics Institute director Nancy Cox, Ph.D., left, poses with Nancy Brown, M.D., chair of the Department of Medicine, before Cox’s recent Flexner Discovery Lecture. Read More

The drug sildenafil, sold as Viagra and other brand names, improves insulin sensitivity in people at risk for diabetes, researchers at Vanderbilt University Medical Center reported. Sildenafil inhibits an enzyme called phosphodiesterase 5 (PDE5), resulting in relaxation of smooth muscle, vasodilation and… Read More

Vanderbilt’s Thomas Wang, M.D., left, Nancy Brown, M.D., and David Bader, Ph.D., explored the human determinants of cardiovascular disease and treatment at last week’s Flexner Discovery Lecture. Read More

Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24. Read More

  Nancy Brown, M.D. Vanderbilt University’s Nancy J. Brown, M.D., chair and physician-in-chief of the Department of Medicine, and James E. Crowe Jr., M.D., director of the Vanderbilt Vaccine Center, are among 70 new members elected to the Institute of Medicine (IOM), the organization… Read More

David Aronoff, M.D., has been named the new director of Vanderbilt University Medical Center’s Division of Infectious Diseases. Read More

High pollen counts could trigger angioedema, a rare adverse reaction of Angiotension converting enzyme (ACE) inhibitors, Vanderbilt University researchers have found. Read More

Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week. Read More

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome. Read More

Vanderbilt researchers are seeking genetic clues to explain why risk factors for AF are more prevalent in African-Americans but their incidence of the disease is lower than European-Americans. Read More

About half of kidney patients will die from heart disease within five years of starting dialysis, yet patients with kidney failure are rarely included in heart disease research. Jorge Gamboa, M.D., T. Alp Ikizler, M.D., and Nancy Brown, M.D., completed a small study that suggests a more personalized approach to… Read More

Fourteen Vanderbilt researchers have been elected fellows of the American Association for the Advancement of Science (AAAS). Read More

The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read More